Presentation TCT 2025 TCT 1120: Percutaneous MitraClip Versus Surgical Mitral Valve Repair or Replacement for Severe Functional Mitral Regurgitation: A Comparative Analysis of Long-Term Clinical Outcomes Presenter: Mehmet Cilingiroglu October 27, 2025
Presentation TCT 2025 TCT 1039: Contemporary short and intermediate term outcomes of patients with acute pulmonary embolism treated with advanced therapies Presenter: Roberto Herrera October 27, 2025
Presentation TCT 2025 TCT 533: Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure Presenter: Jozef Bartunek October 27, 2025
Presentation TCT 2025 TCT 1157: Prognostic value of algorithmically-derived invasive hemodynamic indices of paravalvular regurgitation after TAVR with Self-Expanding Devices for heart failure rehospitalization and all-cause mortality – the APPOSE registry Presenter: Geert Versteeg October 27, 2025
Presentation TCT 2025 TCT 1038: Updated Meta-Analysis of Catheter-Directed Thrombolysis vs. Mechanical Thrombectomy for Intermediate- and High-Risk Pulmonary Embolism: Insights from 5,344 Patients Presenter: Aymen Ahmed October 27, 2025
Presentation TCT 2025 TCT 535: Transcatheter Iatrogenic Atrial Shunting in Patients with Heart Failure: A Systematic Review and Meta-Analysis Presenter: Kyriakos Dimitriadis October 27, 2025
Presentation TCT 2025 TCT 1154: The Relationship Between Race and Post-TAVR Bleeding Outcomes: Analysis from the Trans-Pacific TAVR (TP-TAVR) Registry Presenter: Meghana Iyer October 27, 2025
Presentation TCT 2025 TCT 1037: Factors Associated with Survival-to-Discharge in Patients with High-Risk Pulmonary Embolism Requiring Veno-Arterial Extracorporeal Membrane Oxygenation Presenter: Daniel J. Snyder October 27, 2025
Presentation TCT 2025 TCT 531: Early Clinical Experience with a Chronically-Adjustable, Biatrial Pressure Sensing Interatrial Shunt for Heart Failure: Adona Medical Presenter: Gregg W. Stone October 27, 2025
Presentation TCT 2025 TCT 500: Clinical Outcomes of Patients With ST-Elevation Myocardial Infarction Treated With Drug-coated Balloons, Hybrid Strategies, or Drug-eluting Stents Presenter: Nancy Virginia October 27, 2025
Presentation TCT 2025 TCT 1151: Impact of Perivascular Adipose Tissue Attenuation Around the Aortic Valve on Clinical Outcomes After Transcatheter Aortic Valve Replacement Presenter: Hiroya Okamoto October 27, 2025
Presentation TCT 2025 TCT 1036: Healthcare Resource Utilization and Outcomes in Intermediate-Risk Pulmonary Embolism: Analysis of a U.S. Administrative Database. Presenter: Suhail Dohad October 27, 2025
Presentation TCT 2025 Assessment of Procedural Outcomes After M-TEER: Available Tools and Needs Presenter: Gagan D. Singh October 27, 2025
Presentation TCT 2025 Featured Clinical Research: Outcomes Among Patients with Massive PE after Computer Assisted Vacuum Thrombectomy: New Data from the STRIKE-PE Study Presenter: Andrew Sharp October 27, 2025
Presentation TCT 2025 TCT 1155: Does Experience Pay Off? The Impact of Institutional Volume on TAVR Outcomes Presenter: Priya Joshi October 27, 2025
Presentation TCT 2025 TCT 1127: Sex Differences in Imaging Features and Long-Term Outcomes in Patients with Mitral Valve Prolapse Undergoing Surgery for Mitral Regurgitation Presenter: Revathy Sampath-Kumar October 27, 2025
Presentation TCT 2025 TCT 1153: Determining Cut-off Values of Non-dimensional Aortic Valve Coefficient (AVC) for Functional Assessment of Aortic Stenosis in TAVR Patients: A Prospective Analysis Presenter: Shreyash Manegaonkar October 27, 2025
Presentation TCT 2025 TCT 1156: Comparison of 30-Day Readmission Outcomes Following Transcatheter Aortic Valve Replacement in Patients Aged <65 Versus ≥65 Years: Insights from a National Readmission Database Presenter: Junaid Mir October 27, 2025
Presentation TCT 2025 TCT 1128: Transcatheter Edge-to-Edge versus Surgical Repair for Primary Mitral Regurgitation: Nationwide Utilization, In-Hospital Outcomes, and Costs in the 2022 National Inpatient Sample Presenter: Safee Ullah Haider October 27, 2025
News Conference News TCT 2025 Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION Michael O'Riordan October 26, 2025